Weiner v. Milliken Design, Inc. f/k/a Sylvan Chemical Co., Inc.

CourtCourt of Chancery of Delaware
DecidedJanuary 30, 2015
DocketCA 9671-VCP
StatusPublished

This text of Weiner v. Milliken Design, Inc. f/k/a Sylvan Chemical Co., Inc. (Weiner v. Milliken Design, Inc. f/k/a Sylvan Chemical Co., Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Weiner v. Milliken Design, Inc. f/k/a Sylvan Chemical Co., Inc., (Del. Ct. App. 2015).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

ROBERT S. WEINER, ) ) Plaintiff, ) ) v. ) C.A. No. 9671-VCP ) MILLIKEN DESIGN, INC. f/k/a ) SYLVAN CHEMICAL CO., INC., ) ) Defendant. )

MEMORANDUM OPINION

Date Submitted: October 15, 2014 Date Decided: January 30, 2015

Kevin R. Shannon, Esq., Matthew J. O‟Toole, Esq., Christopher N. Kelly, Esq., POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Steven M. Kushner, Esq., FELLOWS LABRIOLA LLP, Atlanta, Georgia; Attorneys for Plaintiff.

R. Judson Scaggs, Jr., Esq., Leslie A. Polizoti, Esq., Christopher P. Quinn, Esq., MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware; Troy A. Tessier, Esq., Greenville, South Carolina; Attorneys for Defendant.

PARSONS, Vice Chancellor. Before the Court are cross motions for summary judgment, one seeking to compel

arbitration of a post-closing price adjustment pursuant to a stock purchase agreement, and

the other seeking to limit the scope of that arbitration. In particular, the defendant, a

Delaware corporation, contends that certain issues identified by the plaintiff, an

individual formerly employed by that corporation, are not arbitrable under the relevant

agreement. The plaintiff contends that the defendant‟s objections actually go to questions

of procedural arbitrability and should be decided by the arbitrator. For the reasons stated

herein, I agree with the plaintiff and refuse to limit the issues the arbitrator will decide in

the manner requested by the defendant. The parties also disagree about who should serve

as the arbitrator, and espouse different interpretations of the relevant contract provision.

On this point, the parties are directed to submit up to three candidates each who would be

qualified based on the parameters I have specified in this Memorandum Opinion.

I. BACKGROUND1

A. The Parties

Plaintiff and Counterclaim Defendant, Dr. Robert S. Weiner, is an individual

residing in Georgia. Defendant and Counterclaim Plaintiff, Milliken Design, Inc.

(“Milliken”), is a Delaware corporation formerly known as Sylvan Chemical Co., Inc.

Milliken is a privately held textile, chemical, and floor covering company based in

Spartanburg, South Carolina.

1 Except as otherwise noted, the facts are drawn from the well-pled allegations of Weiner‟s Verified Complaint to Compel Arbitration (the “Complaint”).

1 B. Facts

1. The Agreement

In October 2009, Milliken entered into a Stock and Unit Purchase Agreement (the

“Agreement”)2 to acquire several entities owned by Dr. Weiner and his former business

partners: (1) Lineage PCR, Inc., a Delaware corporation (“Lineage PCR”); (2) PCR

Holdings, LLC, a Delaware limited liability company (“PCR Holdings”); (3) Product

Concepts Residential, LLC, a Georgia limited liability company (“Product Concepts”);

and (4) Constantine Dyeing, LLC, also a Georgia limited liability company (collectively,

the “Acquired Companies”).3 Product Concepts, which the Agreement defined as the

“Operating Company,”4 formerly did business as Constantine Carpet.5 Before the

acquisition, Product Concepts and Constantine Dyeing, LLC were subsidiaries of PCR

Holdings, which, in turn, was partly owned by Lineage PCR.

PCR Holdings and Lineage PCR were held by two groups that, together,

comprised the “Sellers” under the Agreement: (1) the “Legacy Owners,” which include

Dr. Weiner and several other entities and individuals; and (2) the “Lineage Owners,”

which include a Delaware limited partnership, Lineage Capital, L.P., and a Delaware

2 Compl. Ex. A [hereinafter “Agreement”]. Capitalized terms not defined herein are used as defined in the Agreement. 3 Agreement § 1 (defining “Acquired Companies”). 4 Id. § 1. 5 Affidavit of Simeon Skinner (“Skinner Aff.”) ¶ 5.

2 limited liability company, Lineage Investors, LLC.6 The Legacy Owners directly held

membership interests in PCR Holdings. The Lineage Owners were the stockholders of

Lineage PCR, and thereby had an indirect interest in PCR Holdings.

Pursuant to the Agreement, Milliken purchased the Acquired Companies by

acquiring all of the outstanding shares and interests of Lineage PCR and PCR Holdings.7

As consideration, Milliken agreed to pay the Sellers roughly $30 million in cash and to

assume roughly $16 million of the Acquired Companies‟ net debt. That $46 million

figure potentially could be adjusted by a “Net Working Capital Adjustment” and certain

“Earnout” payments to yield the total “Purchase Price.”8 Certain of the Sellers were to

receive their full consideration upon closing of the transaction, while others received cash

up front plus the potential for future “Earnout” payments.9 This dispute pertains to the

Agreement‟s Earnout payment mechanism.

2. Payment of Earnouts under the Agreement

a. Earnout calculation

As relevant here, Section 2.6 of the Agreement provided for three potential

Earnout payments: one each at the end of fiscal years 2010, 2011, and 2012. 10 For each

6 Agreement, Preamble. 7 Skinner Aff. ¶ 5. 8 Agreement § 2.2. 9 Id. 10 Id. § 2.6. I note that the relevant fiscal years each span twelve months beginning in late November of the preceding calendar year, such that Fiscal Year 2010 is defined to run from November 30, 2009 to November 28, 2010; Fiscal Year 2011 3 of those years, the Agreement sets out defined “Target Revenue” figures. If, for example,

Fiscal Year 2010 Revenue met or exceeded 2010 Target Revenue, Milliken would pay

$2,333,333 million as an addition to the Purchase Price; if 2010 Revenue was below

Target Revenue, the Agreement provides a formula for computing the “2010 Earnout

Payment,” which would amount to some dollar figure between $0 and the $2,333,333

maximum.11

The same computation is made to determine the 2011 Earnout Payment and the

2012 Earnout Payment.12 With respect to Fiscal Years 2011 and 2012, however, the

Agreement required Milliken to make additional payments in the form of the “2010-2011

Cumulative Earnout” and the “2010-2012 Cumulative Earnout,” respectively. A payment

was owed for the 2011 Cumulative Earnout if the sum of the 2010 Earnout Payment and

the 2011 Earnout Payment was less than a certain threshold; that threshold itself was

dependent on whether “2010-2011 Revenue” exceeded a certain minimum amount.13

The same structure was used to compute the 2010-2012 Cumulative Earnout, except that

the inputs included the 2010 Earnout Payment, the 2011 Earnout Payment, the 2010-2011

Cumulative Earnout, and the 2012 Earnout Payment, and the threshold against which

from November 29, 2010 to November 27, 2011; and Fiscal Year 2012 from November 28, 2011 to December 2, 2012. Id. § 1. Collectively, I refer to these three Fiscal Years as the “Earnout Period.” 11 Id. § 2.6(a); see also id. § 1. 12 Id. §§ 2.6(b)(i), 2.6(c)(i). 13 Id. § 2.6(b)(ii).

4 those payments were measured was “2010-2012 Revenue.”14 The Cumulative Earnout

payments for 2011 or 2012, if any, would be made in addition to the 2011 Earnout

Payment and the 2012 Earnout Payment. The parties agreed that, in any event, the

aggregate payment in respect of the three relevant calculations—(1) the 2010 Earnout

Payment, (2) the 2011 Earnout Payment plus the 2010-2011 Cumulative Earnout, and (3)

the 2012 Earnout Payment plus the 2010-2012 Cumulative Earnout—would not be

greater than $7,000,000 or less than $0.15

b. Earnout payments and disputes

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kennedy v. Silas Mason Co.
334 U.S. 249 (Supreme Court, 1948)
John Wiley & Sons, Inc. v. Livingston
376 U.S. 543 (Supreme Court, 1964)
Kuhn Construction, Inc. v. Diamond State Port Corp.
990 A.2d 393 (Supreme Court of Delaware, 2010)
Schick Inc. v. Amalgamated Clothing & Textile Workers Union
533 A.2d 1235 (Court of Chancery of Delaware, 1987)
Beebe Medical Center, Inc. v. InSight Health Services Corp.
751 A.2d 426 (Court of Chancery of Delaware, 1999)
Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.
616 A.2d 1192 (Supreme Court of Delaware, 1992)
Judah v. Delaware Trust Co.
378 A.2d 624 (Supreme Court of Delaware, 1977)
James & Jackson, LLC. v. Willie Gary, LLC.
906 A.2d 76 (Supreme Court of Delaware, 2006)
United Rentals, Inc. v. RAM Holdings, Inc.
937 A.2d 810 (Court of Chancery of Delaware, 2007)
Nash v. Dayton Superior Corp.
728 A.2d 59 (Court of Chancery of Delaware, 1998)
Delaware Transit Corp. v. Amalgamated Transit Union Local 842
34 A.3d 1064 (Supreme Court of Delaware, 2011)
Viacom International Inc. v. Winshall
72 A.3d 78 (Supreme Court of Delaware, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Weiner v. Milliken Design, Inc. f/k/a Sylvan Chemical Co., Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/weiner-v-milliken-design-inc-fka-sylvan-chemical-c-delch-2015.